Pediatric Surgery International

, Volume 29, Issue 1, pp 79–85 | Cite as

Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia

  • Wei Chen
  • Takaharu Oue
  • Takehisa Ueno
  • Shuichiro Uehara
  • Noriaki Usui
  • Masahiro Fukuzawa
Original Article

Abstract

Purpose

Apelin, the endogenous ligand of the angiotensin-like-receptor 1 (APJ), is thought to play an important role in liver disease. This study investigated the apelin expression in different stages of biliary atresia (BA) and investigated whether it is associated with the progression of disease.

Methods

Liver tissues were obtained from patients at Kasai’s procedure (KP), the follow-up stage after KP (Post-KP) and at liver transplantation (LT). Immunohistochemistry for apelin and its receptor APJ and real-time quantitative reverse transcriptase polymerase chain reaction for apelin mRNA expression were conducted.

Results

The immunohistochemical study revealed that apelin was mainly localized in the perivenular areas of control liver tissue, and slightly detected in the hepatic stellate cells (HSC) and hepatocytes, whereas intense apelin immunoreactivity was detected in perivenular areas, HSC and hepatocytes of LT liver tissue. The apelin mRNA expression level was significantly higher in the LT group than in the KP and Post-KP group. Significant linear correlations were observed between the apelin mRNA level and liver fibrosis, serum total bilirubin and the grade of esophageal varices.

Conclusions

The hepatic apelin–APJ system is markedly activated in the progression of BA, especially in end-stage cirrhosis. The apelin expression level accurately reflects the severity of hepatic fibrosis and esophageal varices and therefore could be used as a prognostic factor in BA patients.

Keywords

Apelin APJ Biliary atresia Liver fibrosis Esophageal varices Liver transplantation 

References

  1. 1.
    Tatemoto K, Hosoya M, Habata Y et al (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 25:471–476CrossRefGoogle Scholar
  2. 2.
    O’Dowd BF, Heiber M, Chan A et al (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136(1–2):355–360PubMedCrossRefGoogle Scholar
  3. 3.
    Ishida J, Hashimoto T, Hashimoto Y et al (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279:26274–26279PubMedCrossRefGoogle Scholar
  4. 4.
    Szokodi I, Tavi P, Foldes G et al (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cadiac contractility. Circ Res 91:434–440PubMedCrossRefGoogle Scholar
  5. 5.
    Boucher J, Masri B, Daviaud D et al (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764–1771PubMedCrossRefGoogle Scholar
  6. 6.
    Wang G, Anini Y, Wei W et al (2004) Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 145:1342–1348PubMedCrossRefGoogle Scholar
  7. 7.
    De Mota N, Reaux-Le Goazigo A, El Messari S et al (2004) Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci 101:10464–10469PubMedCrossRefGoogle Scholar
  8. 8.
    Hiroaki Y, Masaya O, Kazunori Y et al (2011) Overexpression of apelin receptor (APJ/AGTRL1) on hepative stellate cells and sinusoidal angiogenesis in human cirrhotic liver. J Gastroenterol 46:222–231CrossRefGoogle Scholar
  9. 9.
    Principe A, Melgar-Lesmes P, Ferna′ndez-Varo G et al (2008) The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 48:1193–1201PubMedCrossRefGoogle Scholar
  10. 10.
    Yokomori H, Oda M, Yoshimura K et al (2012) Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver. Hepatol Res 42(5):508–514PubMedCrossRefGoogle Scholar
  11. 11.
    Okazaki T, Kobayashi H, Yamataka A et al (1999) Long-term postsurgical outcome of biliary atresia. J Pediatr Surg 34:312–315PubMedCrossRefGoogle Scholar
  12. 12.
    Tajiri T, Yoshida H, Obara K et al (2010) General rules for recording endoscopic findings of esophagogastric varices (2nd edn). Dig Endosc 22:1–9PubMedCrossRefGoogle Scholar
  13. 13.
    Ichida F, Tsuji T, Omata M et al (1996) New Inuyama classification for histological assessment of chronic hepatitis. Hepatol Commun 6:112–119CrossRefGoogle Scholar
  14. 14.
    Lee DK, Cheng R, Nguyen T et al (2000) Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74:34–41PubMedCrossRefGoogle Scholar
  15. 15.
    Hosoya M, Kawamata Y, Fukusumi S et al (2000) Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 275:21061–21067PubMedCrossRefGoogle Scholar
  16. 16.
    Hiroaki Y, Masaya O, Kazunori Y et al (2012) Enhanced expression of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver. Hepatol Res 42:508–514CrossRefGoogle Scholar
  17. 17.
    Kasai M (1974) Treatment of biliary atresia with special reference to hepatic portoenterostomy and its modifications. Prog Pediatr Surg 6:5–52PubMedGoogle Scholar
  18. 18.
    Karrer FM, Price MR, Bensard DD, Sokol RJ, Narkewicz MR, Smith DJ et al (1996) Long-term results with the Kasai operation for biliary atresia. Arch Surg 131:493–496PubMedCrossRefGoogle Scholar
  19. 19.
    Ohi R, Nio M, Chiba T, Endo N, Goto M, Ibrahim M (1990) Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg 25:442–445PubMedCrossRefGoogle Scholar
  20. 20.
    Tagge DU, Tagge EP, Drongowski RA, Oldham KT, Coran AGA (1991) Long term experience with biliary atresia. Ann Surg 214:590–598PubMedCrossRefGoogle Scholar
  21. 21.
    Gautier M, Valayer J, Odièvre M et al (1984) Histological liver evaluation 5 years after surgery for extrahepatic biliary atresia: a study of 20 cases. J Pediatr Surg 19:263–268PubMedCrossRefGoogle Scholar
  22. 22.
    Lykavieris P, Chardot C, Sokhn M et al (2005) Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology 41:366–371PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Wei Chen
    • 1
    • 2
  • Takaharu Oue
    • 1
  • Takehisa Ueno
    • 1
  • Shuichiro Uehara
    • 1
  • Noriaki Usui
    • 1
  • Masahiro Fukuzawa
    • 1
  1. 1.Department of Pediatric SurgeryOsaka University Graduate School of MedicineSuitaJapan
  2. 2.Department of Pediatric SurgeryBeijing Children’s HospitalBeijingChina

Personalised recommendations